Auxilius · 13 hours ago
Accounting Analyst
Auxilius is a fast-growing, venture-backed B2B SaaS company revolutionizing how innovative biotechs manage financial operations. The Accounting Analyst will work with cross-functional teams to help biotech customers optimize their accounting processes and ensure compliance, while also influencing product development based on client feedback.
Responsibilities
Design, implement, and maintain technical accounting workflows within the Auxilius platform
Support accounting-focused onboarding, training, and enablement in partnership with Technical Accounting Success
Perform detailed QA/QC reviews of financial data to ensure accuracy and compliance with accounting standards
Support adherence to client accounting methodologies and internal controls
Provide accounting support through data processing, analysis, and issue resolution
Communicate accounting outcomes and system configurations clearly to clients
Participate in product development testing for accounting features
Translate technical accounting requirements into clear product feedback
Identify opportunities to standardize and improve accounting workflows at scale
Qualification
Required
Bachelor's degree in Accounting, Finance, or related field
2+ years in accounting or finance roles (startup experience preferred)
Advanced Excel and analytical skills
Exceptional attention to detail and problem-solving abilities
Ability to work independently and manage multiple priorities
Interest or experience in healthcare / biotech finance
Collaborative attitude with a sense of humor
Benefits
Premium healthcare
Access to modern health partners like One Medical, Kindbody, Talkspace, and Teladoc
Flexible Spending Account
401(k) that matches 100% of the first 1% you contribute and 50% of the next 5%
Life and disability insurance
Commuter benefits
24/7 well-being resources through Health Advocate
Unlimited PTO
Company
Auxilius
Auxilius provides clinical trial financial management software for Biopharma.
Funding
Current Stage
Early StageTotal Funding
$20MKey Investors
SignalFireRenegade Partners
2024-03-15Series A· $10M
2022-06-16Series A· $10M
Recent News
Company data provided by crunchbase